Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00945763 · ClinicalTrials.gov registry record · Phase 2
Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery
A Phase 2 study, sponsored by Alkermes.
- Completed
- Registry status
- Phase 2
- Development phase
- 230
- Enrollment target
NCT00945763 is a Phase 2 study that has completed, run by Alkermes. The registered enrollment target is 230 participants.
The verdict
NCT00945763, a Phase 2 study, has completed, sponsored by Alkermes.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 230 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of single IV doses of N1539 after dental impaction surgery.
Interventions
- DRUG placebo
- DRUG N1539
- DRUG Motrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00945763
The ClinicalTrials.gov registry entry for NCT00945763 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alkermes, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00945763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00945763 about?
NCT00945763 is a clinical study titled "Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery". To evaluate the safety and efficacy of single IV doses of N1539 after dental impaction surgery.
What is the current status of trial NCT00945763?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 230 participants. The study started on 2009-07. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00945763?
The interventions under investigation include: placebo (DRUG), N1539 (DRUG), Motrin (DRUG).
Who is sponsoring clinical trial NCT00945763?
This trial is sponsored by Alkermes, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.